• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cellular uptake of cyclotide MCoTI-I follows multiple endocytic pathways.环肽 MCoTI-I 的细胞摄取遵循多种内吞途径。
J Control Release. 2011 Oct 30;155(2):134-43. doi: 10.1016/j.jconrel.2011.08.030. Epub 2011 Aug 30.
2
The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis.环状胱氨酸结微小蛋白MCoTI-II通过巨胞饮作用内化进入细胞。
Int J Biochem Cell Biol. 2007;39(12):2252-64. doi: 10.1016/j.biocel.2007.06.016. Epub 2007 Jul 7.
3
Structural and functional characterization of chimeric cyclotides from the Möbius and trypsin inhibitor subfamilies.来自莫比乌斯环和胰蛋白酶抑制剂亚家族的嵌合环肽的结构与功能表征
Biopolymers. 2017 Jan;108(1). doi: 10.1002/bip.22927.
4
Targeted Delivery of Cyclotides via Conjugation to a Nanobody.通过与纳米抗体缀合实现环肽的靶向递送。
ACS Chem Biol. 2018 Oct 19;13(10):2973-2980. doi: 10.1021/acschembio.8b00653. Epub 2018 Oct 5.
5
Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.鉴定和表征一类新的细胞穿透肽家族:环状细胞穿透肽。
J Biol Chem. 2011 Oct 21;286(42):36932-43. doi: 10.1074/jbc.M111.264424. Epub 2011 Aug 26.
6
Backbone dynamics of cyclotide MCoTI-I free and complexed with trypsin.环肽MCoTI-I游离态及与胰蛋白酶复合态的主链动力学
Angew Chem Int Ed Engl. 2010 Sep 17;49(39):7030-4. doi: 10.1002/anie.201002906.
7
Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides.天然和工程化MCoTI环肽的化学合成与仿生全合成。
Org Biomol Chem. 2008 Apr 21;6(8):1462-70. doi: 10.1039/b801667d. Epub 2008 Mar 6.
8
Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications.环肽,一种用于生物技术应用的多功能超稳定微蛋白支架。
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5089-5099. doi: 10.1016/j.bmcl.2017.10.051. Epub 2017 Oct 21.
9
Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity.具有血管紧张素(1-7)样活性的基于MCoTI的环肽的设计。
Molecules. 2016 Jan 26;21(2):152. doi: 10.3390/molecules21020152.
10
Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.调节富含二硫键的环状细胞穿透肽细胞摄取的结构参数:MCoTI-II 和 SFTI-1。
Eur J Med Chem. 2014 Dec 17;88:10-8. doi: 10.1016/j.ejmech.2014.06.047. Epub 2014 Jun 24.

引用本文的文献

1
Plant Defense Peptides: Exploring the Structure-Function Correlation for Potential Applications in Drug Design and Therapeutics.植物防御肽:探索结构-功能相关性及其在药物设计与治疗中的潜在应用
ACS Omega. 2025 Feb 18;10(8):7583-7596. doi: 10.1021/acsomega.4c11339. eCollection 2025 Mar 4.
2
Molecular Chimera in Cancer Drug Discovery: Beyond Antibody Therapy, Designing Grafted Stable Peptides Targeting Cancer.癌症药物发现中的分子嵌合体:超越抗体疗法,设计靶向癌症的嫁接稳定肽
Int J Pept Res Ther. 2025;31(3):38. doi: 10.1007/s10989-025-10690-6. Epub 2025 Feb 17.
3
Small and Versatile Cyclotides as Anti-infective Agents.小型多功能环肽作为抗感染剂
ACS Infect Dis. 2025 Feb 14;11(2):386-397. doi: 10.1021/acsinfecdis.4c00957. Epub 2025 Jan 22.
4
Research Progress on Cyclic-Peptide Functionalized Nanoparticles for Tumor-Penetrating Delivery.用于肿瘤渗透递送的环肽功能化纳米颗粒的研究进展
Int J Nanomedicine. 2024 Nov 26;19:12633-12652. doi: 10.2147/IJN.S487303. eCollection 2024.
5
Resistance is futile: targeting multidrug-resistant bacteria with Cys-rich cyclic polypeptides.抵抗是徒劳的:用富含半胱氨酸的环肽靶向多重耐药细菌。
RSC Chem Biol. 2023 Aug 21;4(10):722-735. doi: 10.1039/d3cb00015j. eCollection 2023 Oct 4.
6
Native and Engineered Cyclic Disulfide-Rich Peptides as Drug Leads.天然和工程化的富含环二硫键的肽类作为药物先导物。
Molecules. 2023 Apr 3;28(7):3189. doi: 10.3390/molecules28073189.
7
Plant microProteins: Small but powerful modulators of plant development.植物微小蛋白:植物发育的小而强大的调节因子。
iScience. 2022 Oct 21;25(11):105400. doi: 10.1016/j.isci.2022.105400. eCollection 2022 Nov 18.
8
Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development.利用环肽支架在药物研发中靶向生物分子相互作用。
Molecules. 2022 Sep 29;27(19):6430. doi: 10.3390/molecules27196430.
9
Targeting intracellular protein-protein interactions with macrocyclic peptides.靶向细胞内蛋白-蛋白相互作用的大环肽。
Trends Pharmacol Sci. 2022 Mar;43(3):234-248. doi: 10.1016/j.tips.2021.11.008. Epub 2021 Dec 13.
10
Importance of the Cyclic Cystine Knot Structural Motif for Immunosuppressive Effects of Cyclotides.环胱氨酸结结构基序对环肽免疫抑制作用的重要性。
ACS Chem Biol. 2021 Nov 19;16(11):2373-2386. doi: 10.1021/acschembio.1c00524. Epub 2021 Sep 30.

本文引用的文献

1
Chemical Synthesis of a Circular Protein Domain: Evidence for Folding-Assisted Cyclization.环状蛋白质结构域的化学合成:折叠辅助环化的证据。
Angew Chem Int Ed Engl. 1998 Feb 16;37(3):347-349. doi: 10.1002/(SICI)1521-3773(19980216)37:3<347::AID-ANIE347>3.0.CO;2-5.
2
Discovery of an unusual biosynthetic origin for circular proteins in legumes.在豆科植物中发现环状蛋白的一种不寻常生物合成起源。
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10127-32. doi: 10.1073/pnas.1103660108. Epub 2011 May 18.
3
Macropinocytosis: an endocytic pathway for internalising large gulps.巨胞饮作用:一种内化大剂量物质的胞吞途径。
Immunol Cell Biol. 2011 Nov;89(8):836-43. doi: 10.1038/icb.2011.20. Epub 2011 Mar 22.
4
Biological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics.天然和工程化环肽的生物学活性,一种基于肽的治疗药物的新型分子支架。
Curr Mol Pharmacol. 2010 Nov;3(3):153-63. doi: 10.2174/1874467211003030153.
5
Naturally occurring circular proteins: distribution, biosynthesis and evolution.天然环状蛋白质:分布、生物合成和进化。
Org Biomol Chem. 2010 Nov 21;8(22):5035-47. doi: 10.1039/c0ob00139b. Epub 2010 Sep 7.
6
Backbone dynamics of cyclotide MCoTI-I free and complexed with trypsin.环肽MCoTI-I游离态及与胰蛋白酶复合态的主链动力学
Angew Chem Int Ed Engl. 2010 Sep 17;49(39):7030-4. doi: 10.1002/anie.201002906.
7
Cyclotides, a promising molecular scaffold for peptide-based therapeutics.环肽,一种有前途的基于肽的治疗药物的分子支架。
Biopolymers. 2010;94(5):611-6. doi: 10.1002/bip.21433.
8
Circular proteins and mechanisms of cyclization.环状蛋白质和环化机制。
Biopolymers. 2010;94(5):573-83. doi: 10.1002/bip.21422.
9
Virus movements on the plasma membrane support infection and transmission between cells.病毒在质膜上的运动有助于细胞间的感染和传播。
PLoS Pathog. 2009 Nov;5(11):e1000621. doi: 10.1371/journal.ppat.1000621. Epub 2009 Nov 26.
10
FLIP-mediated autophagy regulation in cell death control.FLIP介导的自噬调控在细胞死亡控制中的作用
Nat Cell Biol. 2009 Nov;11(11):1355-62. doi: 10.1038/ncb1980. Epub 2009 Oct 18.

环肽 MCoTI-I 的细胞摄取遵循多种内吞途径。

Cellular uptake of cyclotide MCoTI-I follows multiple endocytic pathways.

机构信息

Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA 90033, USA.

出版信息

J Control Release. 2011 Oct 30;155(2):134-43. doi: 10.1016/j.jconrel.2011.08.030. Epub 2011 Aug 30.

DOI:10.1016/j.jconrel.2011.08.030
PMID:21906641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3195939/
Abstract

Cyclotides are plant-derived proteins that naturally exhibit various biological activities and whose unique cyclic structure makes them remarkably stable and resistant to denaturation or degradation. These attributes, among others, make them ideally suited for use as drug development tools. This study investigated the cellular uptake of cyclotide, MCoTI-I in live HeLa cells. Using real time confocal fluorescence microscopy imaging, we show that MCoTI-I is readily internalized in live HeLa cells and that its endocytosis is temperature-dependent. Endocytosis of MCoTI-I in HeLa cells is achieved primarily through fluid-phase endocytosis, as evidenced by its significant colocalization with 10K-dextran, but also through other pathways as well, as evidenced by its colocalization with markers for cholesterol-dependent and clathrin-mediated endocytosis, cholera toxin B and EGF respectively. Uptake does not appear to occur only via macropinocytosis as inhibition of this pathway by Latrunculin B-induced disassembly of actin filaments did not affect MCoTI-I uptake and treatment with EIPA which also seemed to inhibit other pathways collectively inhibited approximately 80% of cellular uptake. As well, a significant amount of MCoTI-I accumulates in late endosomal and lysosomal compartments and MCoTI-I-containing vesicles continue to exhibit directed movements. These findings demonstrate internalization of MCoTI-I through multiple endocytic pathways that are dominant in the cell type investigated, suggesting that this cyclotide has ready access to general endosomal/lysosomal pathways but could readily be re-targeted to specific receptors through addition of targeting ligands.

摘要

环肽是一类从植物中提取的蛋白质,天然具有多种生物活性,其独特的环状结构使其具有显著的稳定性,能够抵抗变性或降解。这些特性使它们成为药物开发工具的理想选择。本研究探讨了环肽 MCoTI-I 在活 HeLa 细胞中的细胞摄取。通过实时共聚焦荧光显微镜成像,我们表明 MCoTI-I 易于被活 HeLa 细胞内化,其内化过程依赖于温度。MCoTI-I 在 HeLa 细胞中的内吞作用主要通过液相内吞实现,这一点从其与 10K-葡聚糖的显著共定位可以得到证明,但也通过其他途径实现,这一点从其与胆固醇依赖性内吞和网格蛋白介导内吞的标记物霍乱毒素 B 和 EGF 的共定位也可以得到证明。摄取似乎并非仅通过大胞饮作用发生,因为 Latrunculin B 诱导的肌动蛋白丝解聚抑制该途径不会影响 MCoTI-I 的摄取,而 EIPA 的处理似乎也抑制了其他途径,共同抑制了约 80%的细胞摄取。此外,大量的 MCoTI-I 积聚在晚期内体和溶酶体腔室中,并且含有 MCoTI-I 的囊泡继续表现出定向运动。这些发现表明 MCoTI-I 通过多种内吞途径被内化,这些途径在研究的细胞类型中占主导地位,这表明这种环肽可以轻易地进入一般的内体/溶酶体途径,但通过添加靶向配体,它可以很容易地被重新靶向到特定的受体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/d2dd432bdbab/nihms322801f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/a6aa7d74f409/nihms322801f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/f7100df6b680/nihms322801f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/a0306c78a12f/nihms322801f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/bcfddcdfdf10/nihms322801f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/166621c39814/nihms322801f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/7943a9a199d0/nihms322801f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/32dc2538c6c9/nihms322801f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/fdb7b1556aae/nihms322801f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/d2dd432bdbab/nihms322801f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/a6aa7d74f409/nihms322801f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/f7100df6b680/nihms322801f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/a0306c78a12f/nihms322801f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/bcfddcdfdf10/nihms322801f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/166621c39814/nihms322801f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/7943a9a199d0/nihms322801f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/32dc2538c6c9/nihms322801f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/fdb7b1556aae/nihms322801f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aed/3195939/d2dd432bdbab/nihms322801f9.jpg